Differential roles of BCL-XL and BCL-2 in protecting mitochondria against oxidative stress in CML cells

被引：0
|
作者：
Zhang, Hui [1 ]
Lu, Weiqin [1 ]
Liu, Terrence [1 ]
Chen, Gang [1 ]
Chen, Zhao [1 ]
Trachootham, Dunyaporn [1 ]
Arlinghaus, Ralph B. [1 ]
Huang, Peng [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2007
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists
    Schroeder, Gretchen M.
    Wei, Donna
    Banfi, Patrizia
    Cai, Zhen-Wei
    Lippy, Jonathan
    Menichincheri, Maria
    Modugno, Michele
    Naglich, Joseph
    Penhallow, Becky
    Perez, Heidi L.
    Sack, John
    Schmidt, Robert J.
    Tebben, Andrew
    Yan, Chunhong
    Zhang, Liping
    Galvani, Arturo
    Lombardo, Louis J.
    Borzilleri, Robert M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3951 - 3956
  • [22] A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2
    Renault, Thibaud T.
    Dejean, Laurent M.
    Manon, Stephen
    MECHANISMS OF AGEING AND DEVELOPMENT, 2017, 161 : 201 - 210
  • [23] Towards the next generation of dual Bcl-2/Bcl-xL inhibitors
    Varnes, Jeffrey G.
    Gero, Thomas
    Huang, Shan
    Diebold, R. Bruce
    Ogoe, Claude
    Grover, Paul T.
    Su, Mei
    Mukherjee, Prasenjit
    Saeh, Jamal Carlos
    MacIntyre, Terry
    Repik, Galina
    Dillman, Keith
    Byth, Kate
    Russell, Daniel John
    Ioannidis, Stephanos
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3026 - 3033
  • [24] Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists
    Perez, Heidi L.
    Banfi, Patrizia
    Bertrand, Jay
    Cai, Zhen-Wei
    Grebinski, James W.
    Kim, Kyoung
    Lippy, Jonathan
    Modugno, Michele
    Naglich, Joseph
    Schmidt, Robert J.
    Tebben, Andrew
    Vianello, Paola
    Wei, Donna D.
    Zhang, Liping
    Galvani, Arturo
    Lombardo, Louis J.
    Borzilleri, Robert M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3946 - 3950
  • [25] Subcellular distribution and function of Bcl-2 and Bcl-xL in the beta cell
    Luciani, D. S.
    Widenmaier, S.
    Yeung, J.
    McIntosh, C.
    Johnson, J. D.
    DIABETOLOGIA, 2008, 51 : S218 - S219
  • [26] Heterodimerization of Bcl-2 and BcL-XL with Bax and Bad in colorectal cancer
    Hattori, T
    Ookawa, N
    Fujita, R
    Fukuchi, K
    ACTA ONCOLOGICA, 2000, 39 (04) : 495 - 500
  • [27] Modulation of synaptic transmission by the BCL-2 family protein BCL-xL
    Jonas, EA
    Hoit, D
    Hickman, JA
    Brandt, TA
    Polster, BM
    Fannjiang, Y
    McCarthy, E
    Montanez, MK
    Hardwick, JM
    Kaczmarek, LK
    JOURNAL OF NEUROSCIENCE, 2003, 23 (23): : 8423 - 8431
  • [28] Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL
    Bruncko, Milan
    Oost, Thorsten K.
    Belli, Barbara A.
    Ding, Hong
    Joseph, Mary K.
    Kunzer, Aaron
    Martineau, Darlene
    McClellan, William J.
    Mitten, Michael
    ng, Shi-Chu Ng
    Nimmer, Paul M.
    Oltersdorf, Tilman
    Park, Cheol-Min
    Petros, Andrew M.
    Shoemaker, Alexander R.
    Song, Xiaohong
    Wang, Xilu
    Wendt, Michael D.
    Zhang, Haichao
    Fesik, Stephen W.
    Rosenberg, Saul H.
    Elmore, Steven W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) : 641 - 662
  • [29] Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2
    Yoshihito Morimoto
    Kimihiko Takada
    Osamu Takeuchi
    Kazuhiro Watanabe
    Masayoshi Hirohara
    Tomoyuki Hamamoto
    Yutaka Masuda
    Molecular and Cellular Biochemistry, 2020, 472 : 187 - 198
  • [30] Roles of Bax, Bcl-xL and Bcl-2 in TEL-FGFR3 associated oncogenic property
    Okamura, D
    Yagasaki, F
    Maeda, T
    Ishikawa, M
    Innai, I
    Bessho, M
    BLOOD, 2005, 106 (11) : 174B - 174B
12345